|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0200 USD | +19,900.00% |
|
+6,566.67% | - |
| Fiscal Period: September | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
Revenues | 334K | 256K | 194K | 131K | 130K | |
Total Revenues | 334K | 256K | 194K | 131K | 130K | |
Gross Profit | 334K | 256K | 194K | 131K | 130K | |
Selling General & Admin Expenses, Total | 335K | 274K | 265K | 1.25M | 2.55M | |
Provision for Bad Debts | - | - | - | 7.75K | 31.09K | |
R&D Expenses | 208K | 23.04K | - | 16.54K | - | |
Amortization of Goodwill and Intangible Assets - (IS) | 625K | - | - | - | - | |
Other Operating Expenses, Total | 1.17M | 297K | 265K | 1.27M | 2.58M | |
Operating Income | -833K | -40.73K | -70.68K | -1.14M | -2.45M | |
Interest Expense, Total | -182K | -49.67K | -50.51K | -528K | -364K | |
Net Interest Expenses | -182K | -49.67K | -50.51K | -528K | -364K | |
Currency Exchange Gains (Loss) | -7.52K | 331 | 408 | -996 | -1.19K | |
Other Non Operating Income (Expenses) | - | 3.13K | 1.75K | 1.5K | 1.5K | |
EBT, Excl. Unusual Items | -1.02M | -86.94K | -119K | -1.67M | -2.82M | |
Asset Writedown | - | - | - | - | - | |
Other Unusual Items | - | 77.12K | - | - | - | |
EBT, Incl. Unusual Items | -1.02M | -9.82K | -119K | -1.67M | -2.82M | |
Earnings From Continuing Operations | -1.02M | -9.82K | -119K | -1.67M | -2.82M | |
Net Income to Company | -1.02M | -9.82K | -119K | -1.67M | -2.82M | |
Net Income - (IS) | -1.02M | -9.82K | -119K | -1.67M | -2.82M | |
Net Income to Common Incl Extra Items | -1.02M | -9.82K | -119K | -1.67M | -2.82M | |
Net Income to Common Excl. Extra Items | -1.02M | -9.82K | -119K | -1.67M | -2.82M | |
Per Share Items | ||||||
Net EPS - Basic | -0.15 | -0 | -0.02 | -0.23 | -0.34 | |
Basic EPS - Continuing Operations | -0.15 | -0 | -0.02 | -0.23 | -0.34 | |
Basic Weighted Average Shares Outstanding | 6.91M | 6.82M | 6.82M | 7.27M | 8.36M | |
Net EPS - Diluted | -0.15 | -0 | -0.02 | -0.23 | -0.34 | |
Diluted EPS - Continuing Operations | -0.15 | -0 | -0.02 | -0.23 | -0.34 | |
Diluted Weighted Average Shares Outstanding | 6.91M | 6.82M | 6.82M | 7.27M | 8.36M | |
Normalized Basic EPS | -0.09 | -0.01 | -0.01 | -0.14 | -0.21 | |
Normalized Diluted EPS | -0.09 | -0.01 | -0.01 | -0.14 | -0.21 | |
Supplemental Items | ||||||
EBITDA | -208K | 584K | - | - | - | |
EBITA | -208K | -40.73K | -70.68K | -1.14M | -2.45M | |
EBIT | -833K | -40.73K | -70.68K | -1.14M | -2.45M | |
Normalized Net Income | -639K | -54.34K | -74.39K | -1.04M | -1.76M | |
Interest on Long-Term Debt | - | - | 49.34K | 479K | 364K | |
Supplemental Operating Expense Items | ||||||
Marketing Expenses | - | - | - | 336K | 91.16K | |
Selling and Marketing Expenses | - | - | - | 336K | 91.16K | |
General and Administrative Expenses | - | - | - | 873K | 2.43M | |
Research And Development Expense From Footnotes | 208K | 23.04K | - | 16.54K | - | |
Stock-Based Comp., Other (Total) | 1.2K | - | - | 656K | 141K | |
Total Stock-Based Compensation | 1.2K | - | - | 656K | 141K |
Select your edition
All financial news and data tailored to specific country editions
















